Overview

Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)

Status:
Completed
Trial end date:
2006-04-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and pharmacokinetics of Org 25969 in subjects with normal or impaired renal function and to evaluate the safety of Org 25969 in subjects with impaired renal function.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.